Aditxt, Inc. Amortization
Aditxt, Inc. (ADTX) reported Amortization of $26.75 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2023-08-14
- Aditxt, Inc. amortization for the quarter ending 2023-06-30 was $26.75K, a 0.00% change year-over-year.
- Aditxt, Inc. amortization for the quarter ending 2022-06-30 was $26.75K, a 0.28% increase year-over-year.
- Aditxt, Inc. amortization for the quarter ending 2021-06-30 was $26.68K.
- Aditxt, Inc. amortization for the quarter ending 2020-06-30 was $0.00.
| Period end | Amortization 3 month | Amortization 6 month |
|---|---|---|
| 2023-06-30 | $26.75K 10-Q · filed 2023-08-14 | $53.50K 10-Q · filed 2023-08-14 |
| 2022-06-30 | $26.75K 10-Q · filed 2023-08-14 | $53.50K 10-Q · filed 2023-08-14 |
| 2021-06-30 | $26.68K 10-Q · filed 2021-08-12 | $53.06K 10-Q · filed 2021-08-12 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |